Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10486453 | 1.00 | HDAC3 (0.44) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL1171067 | 1.00 | HDAC3 (0.44) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL30363039 | 1.00 | HDAC3 (0.44) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL22988497 | 0.97 | HDAC3 (0.42) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL1171542 | 0.96 | HDAC3 (0.40) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL6662250 | 0.96 | HDAC3 (0.40) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4957477 | 0.94 | HDAC3 (0.41) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4160763 | 0.91 | HDAC3 (0.39) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL9579675 | 0.90 | — | — | |
| SCHEMBL17451142 | 0.89 | HDAC3 (0.35) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158775-B2 | Method for detaching protecting group on nucleic acid | NIPPON SHINYAKU CO., LTD. (JP) | 2012-04-17 | — | — | US | claimed |
| US-12509485-B2 | Method for producing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12509483-B2 | Method for producing nucleic acid oligomers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250145655-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-05-08 | — | — | US | disclosed |
| CN-114502566-B | Method for producing nucleic acid oligomer | 住友化学株式会社 | 2025-02-11 | — | — | CN | disclosed |
| EP-4488282-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | Sumitomo Chemical Company, Limited (JP) | 2025-01-08 | — | — | EP | disclosed |
| US-20240116977-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20240051986-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-15 | — | — | US | disclosed |
| WO-2023182274-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | 住友化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-4219520-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-1995252-A1 | METHOD FOR REMOVAL OF NUCLEIC ACID-PROTECTING GROUP | Nippon Shinyaku Co., Ltd. (JP) | 2008-11-26 | — | — | EP | disclosed |
| EP-1548039-B1 | PHOTOPOLYMERIZABLE COMPOSITION AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7307107-B2 | Photopolymerizable composition and use thereof | MITSUI CHEMICALS, INC. (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20070282097-A1 | Phosphoramidite Compound And Method For Producing Oligo-Rna | NIPPON SHINYAKU CO., LTD. (JP) | 2007-12-06 | — | — | US | disclosed |
| EP-1795536-A1 | PHOSPHORAMIDITE COMPOUND AND METHOD FOR PRODUCING OLIGO-RNA | Nippon Shinyaku Co., Ltd. (JP) | 2007-06-13 | — | — | EP | disclosed |
| US-20060003261-A1 | Photopolymerizable composition and use thereof | MITSUI CHEMICALS, INC. (JP) | 2006-01-05 | — | — | US | disclosed |
| EP-1548039-A1 | PHOTOPOLYMERIZABLE COMPOSITION AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-5767212-A | RADICALLY POLYMERIZING ACRYLATE MONOMER CONTAINING SULFUR | TORAY INDUSTRIES, INC. (JP) | 1998-06-16 | — | — | US | disclosed |
| EP-0609454-B1 | PROCESS FOR PRODUCING CLEAR SULFUR-CONTAINING POLYMER | TORAY INDUSTRIES (JP) | 1997-10-22 | — | — | EP | disclosed |
| EP-0609454-A1 | PROCESS FOR PRODUCING CLEAR SULFUR-CONTAINING POLYMER | TORAY INDUSTRIES, INC. (JP) | 1994-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145655-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | POLRMT, RNGTT, POLM | HDAC3 3522/4885HDAC4 3364/4885HDAC1 3946/4885 |
| US-20240051986-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | POLRMT, NOP2, POLN | HDAC3 2518/4885HDAC4 1069/4885HDAC1 3256/4885 |
| US-12509483-B2 | Method for producing nucleic acid oligomers | POLM, RNGTT, POLRMT | HDAC3 3505/4885HDAC4 3044/4885HDAC1 4370/4885 |
| US-12509485-B2 | Method for producing nucleic acid oligomer | RNGTT, POLM, NSUN2 | HDAC3 3452/4885HDAC4 2435/4885HDAC1 3651/4885 |
| US-20070282097-A1 | Phosphoramidite Compound And Method For Producing Oligo-Rna | NSUN2, NSUN3, XRN2 | HDAC3 2661/4885HDAC4 3435/4885HDAC1 2439/4885 |
| US-20240116977-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS | NOP2, DIS3, POLRMT | HDAC3 2227/4885HDAC4 1712/4885HDAC1 3279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.